Related references
Note: Only part of the references are listed.Galectin-1 and Galectin-3 Expression in Lesional Skin of Patients With Systemic Sclerosis-Association With Disease Severity
Gabriela Fernanda Mora et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Gender-Related Differences in Heart Failure Biomarkers
German Cediel et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Anna Stochmal et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)
Diagnostic Power of Galectin-3 in Rheumatic Diseases
Ewa Gruszewska et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
Santiago P. Mendez-Huergo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
Maria T. Elola et al.
CELLULAR IMMUNOLOGY (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Existing and novel biomarkers for precision medicine in systemic sclerosis
Peter J. Wermuth et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Galectin-3 is an independent predictor of survival in systemic sclerosis
Reka Faludi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters
Milan Hromadka et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation
Victoria Sundblad et al.
JOURNAL OF IMMUNOLOGY (2017)
Translating the 'Sugar Code' into Immune and Vascular Signaling Programs
Juan P. Cerliani et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies
Judy R. van Beijnum et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy
Koichi Yanaba et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci et al.
CELL (2014)
Serum galectin-3 level in systemic sclerosis
Suleyman Serdar Koca et al.
CLINICAL RHEUMATOLOGY (2014)
Galectin-3 in angiogenesis and metastasis
Tatsuyoshi Funasaka et al.
GLYCOBIOLOGY (2014)
Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis
Juan I. Baston et al.
JOURNAL OF PATHOLOGY (2014)
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Liu-cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells
Sanja Dabelic et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2012)
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Diego O. Croci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Serum Levels of Galectin-3: Possible Association with Fibrosis, Aberrant Angiogenesis, and Immune Activation in Patients with Systemic Sclerosis
Takashi Taniguchi et al.
JOURNAL OF RHEUMATOLOGY (2012)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
